Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of Vaxigrip Tetra in children 3–11 years (intramuscular)
2021-003804-42Phase 4Completed
- Sponsor
- Helse Bergen
- Start
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of quadrivalent influenza vaccine in influenza, sponsored by Helse Bergen. Primary endpoint: HAI antibody titres on D0 and D58. Started Aug 2021; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2021-003804-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003804-42.